Toggle navigation
About
About The ASCO Post
Editorial Board
Rights and Permissions
Contact
Subscribe
News
FDA Update
Journal Spotlight
Expert's Corner
In the Clinic
View By Issue
View All
Meetings
2024 World Cancer Congress
ESMO Congress 2024
2024 IASLC WCLC
2024 Debates and Didactics in Hematology and Oncology
European Association for the Study of Diabetes Annual Meeting 2024
Calendar
View All
Topics
Breast Cancer
Lung Cancer
Prostate Cancer
Lymphoma
Cardio-oncology
View All
Videos
Newsreels
Video Roundtables
Podcasts
Subscribe
Advertisement
Search Results
Advertisement
«
1
»
Advertisement
Advertisement
Sep
18
Today In Oncology
AACR Cancer Progress Report Features Breakthroughs in Cancer Science and Persistent Inequities in Care
AEGEAN Update Confirms Benefit of Perioperative Durvalumab in Resectable NSCLC
Addition of Palliative Radiotherapy to Best Supportive Care in Painful Hepatic Cancer
FDA Approves Pembrolizumab With Chemotherapy for Unresectable Advanced or Metastatic Malignant Pleural Mesothelioma
FDA Draft Guidance on Conducting Multiregional Oncology Clinical Trials
View More
Advertisement
